>
The current "UFO/UAP disclosure" campaign is not a grassroots or independent effort.
Scientists Discover A 113-million-year-old Pterosaur Wing Preserved In Extraordinary Detail
States Finally Begin to Roll Back Free Healthcare for Illegal Aliens
Trump's ready to reopen mental institutions and liberals are furious…
Heads up: Apparently the government is hiding cameras inside fake utility boxes
Sodium Batteries And EVs That Power The Grid: Inside GM's Big Energy Push
NUCLEAR ENGINE - UNLIMITED LUXURY - 20 YEARS WITHOUT REFUELING
China Unveils Nuclear-Powered Floating Hub For Green Shipping
China Launches World's 1st Commercial Brain Chip, Beating Elon Musk's Neuralink!
Modular next-gen US nuclear reactor goes critical
This Company Will Add Phone, AirPod, and Smartwatch Trackers to License Plate Readers
Elon Details SpaceX AI Data Center in Space Details and Roadmap

"Technocracy is the science of social engineering," says Patrick Wood, author of Technocracy Rising.
Social engineering used to mean molding the minds of people to conform to new norms. This goes back to 1928, Ed Bernays, and his book Propaganda. However, in a Technocracy, not only minds, but bodies, too, can be molded. If you did not get the memo, Technocracy has brought humanity from Human to Posthuman and Transhuman.
In the 2022 Journal Global Trends, Russian scientists describe the difference between Posthuman and Transhuman:
The fundamental idea of posthumanism is the rejection of biological, ethical, and ontological anthropocentrism. Transhumanism focuses on changing and improving natural human characteristics through biological, technological, and cognitive modifications…Transhumanism has the potential to preserve man as an effective economic and cognizing agent.
In other words, man as an "economic agent" refers to the cybernetic human as a commodity in a modern world. This means the laws of the nations need to change to catch up.
The U.S. FDA is meeting that goal for change with its FDA Modernization Act 2.0. What is the FDA Modernization Act 2.0?
The new law amends the Federal Food, Drug, and Cosmetic Act by authorizing sponsors of novel drugs to make use of "certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.